InsideTrading SEC Form 4 insider trades

Stocks

BMEA Biomea Fusion, Inc.

Healthcare · Market cap: $42.2M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $86.8K, sold $0 2022-Q2: bought $0, sold $407.6K 2022-Q3: bought $0, sold $388.5K 2022-Q4: bought $70.9K, sold $0 2023-Q1: bought $12.0M, sold $6.2M 2023-Q2: bought $0, sold $19.5M 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $55.4K, sold $0 2024-Q3: bought $100.6K, sold $0 2024-Q4: bought $0, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $196.4K, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $12.0M) Sold, below the line (largest quarter $19.5M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$86.8K$0
2022-Q2$0$407.6K
2022-Q3$0$388.5K
2022-Q4$70.9K$0
2023-Q1$12.0M$6.2M
2023-Q2$0$19.5M
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$55.4K$0
2024-Q3$100.6K$0
2024-Q4$0$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$196.4K$0
2026-Q1$0$0
2026-Q2$0$0
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$12.5M10 buy days
Sold$26.6M9 sell days
Net insider flow-$14.0Mnet selling · 5 years
Latest trade2025-12-11Erdtmann Rainer M
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2025-12-11 Buy Erdtmann Rainer M Director 30,000 $1.43 $42.9K 1
2025-12-02 Buy Hitchcock Michael J.M. CEO 100,000 $0.99 $99.0K 1
2025-12-01 Buy Erdtmann Rainer M Director 10,000 $1.05 $10.5K 1
2025-11-28 Buy Erdtmann Rainer M Director 40,000 $1.10 $44.0K 1
2024-09-30 Buy Hitchcock Michael J.M. Director 10,000 $10.06 $100.6K 1
2024-06-11 Buy Valle Franco CFO 12,509 $4.43 $55.4K 1
2023-06-01 Sell A2A Pharmaceuticals, Inc. 10% owner 50,000 $34.56 $1.7M 1
2023-05-31 Sell A2A Pharmaceuticals, Inc. 10% owner 75,000 $33.81 $2.5M 1
2023-05-12 Sell A2A Pharmaceuticals, Inc. 10% owner 25,000 $33.84 $846.0K 1
2023-05-09 Sell A2A Pharmaceuticals, Inc. 10% owner 150,000 $34.50 $5.2M 1
2023-05-08 Sell A2A Pharmaceuticals, Inc. 10% owner 100,000 $33.99 $3.4M 1
2023-04-20 Sell A2A Pharmaceuticals, Inc. 10% owner 200,000 $29.12 $5.8M 1
2023-03-31 Sell A2A Pharmaceuticals, Inc. 10% owner 200,000 $31.25 $6.2M 1
2023-03-30 Buy Chen Bihua Director 400,000 $30.00 $12.0M 1
2022-11-14 Buy Hitchcock Michael J.M. Director 5,000 $7.93 $39.6K 1
2022-11-11 Buy Valle Franco CFO 4,100 $7.63 $31.3K 1
2022-07-21 Sell A2A Pharmaceuticals, Inc. 10% owner 34,658 $11.21 $388.5K 1
2022-06-24 Sell A2A Pharmaceuticals, Inc. 10% owner 34,658 $11.76 $407.6K 1
2022-01-14 Buy Valle Franco CFO 10,000 $8.68 $86.8K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
A2A Pharmaceuticals, Inc. 10% owner $0 $26.6M 2023-06-01
Chen Bihua Director $12.0M $0 2023-03-30
Hitchcock Michael J.M. CEO $239.2K $0 2025-12-02
Valle Franco CFO $173.5K $0 2024-06-11
Erdtmann Rainer M Director $97.4K $0 2025-12-11

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2021-08-17 → 2021-09-17 4 $2.0M 65 +0.8% (+5.2% raw)-25.9% (-25.6% raw)-47.5% (-53.7% raw) closed
2021-04-15 → 2021-04-20 3 $21.4M 51 -6.6% (-7.7% raw)-3.3% (+3.8% raw)-41.8% (-42.5% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.